Inside China's R&D powerhouse: Strategic Insights for Pharma leaders

Join us for our third episode! KYBORA's CEO Alan Vanderborght invites Dr. Weiyong Sun, Chief Business Officer at Hansoh Bio, for an insightful conversation about current issues in the industry, including the impact of China's growing R&D capabilities on the US pharmaceutical business.